Gilead Sciences | GILD - Ebit





Ebit Veränderung Datum
AbbVie USD 6.72B 1.99B 2026-06
Agios Pharmaceuticals USD -110.02M 11.55M 2026-03
ALKERMES USD -65.93M 17.65M 2026-06
Alnylam Pharmaceuticals USD 179.66M 67.06M 2026-09
Amgen USD 4.61B 777M 2026-06
Biogen USD 419.5M 663.3M 2026-09
BioMarin Pharmaceutical USD 105.6M 24.04M 2026-06
Bristol-Myers Squibb USD 255M 44M 2026-09
Coherus Biosciences USD -39.08M 3.65M 2025-12
Eli Lilly USD 13.09B 635M 2026-09
Gilead Sciences USD 3.85B 1.17B 2026-06
GlaxoSmithKline GBP 2.86B 251M 2026-09
Glaxosmithkline GBP 2.31B 14.92M 2026-03
Incyte USD -707.47M 1.41B 2026-09
J&J USD 6.47B 1B 2026-09
Merck USD 7.33B 6.49B 2026-09
Moderna USD -815M 573M 2026-06
Neurocrine Biosciences USD 219.9M 5.3M 2026-06
Novartis USD 4.73B 549M 2026-06
Pfizer USD -180M 5.16B 2026-06
PTC Therapeutics USD 146.03M 100.14M 2026-06
Puma Biotechnology USD -2.2M 11.41M 2024-06
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Sanofi EUR 1.12B 811M 2026-06
Sarepta Therapeutics USD 13.29M 345.14M 2026-06
United Therapeutics USD 375.6M 49.8M 2026-06
Vertex Pharmaceuticals USD 1.27B 129.9M 2026-06